MedTrace Logo

UCLA Health Patient Health Maintenance Text Reminder July 2023

NCT05979987 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6894

Last updated 2025-07-02

No results posted yet for this study

Summary

This is a prospective randomized clinical trial evaluating how behaviorally-informed outreach text message reminders impact patient engagement with primary care. This prospective randomized control trial is being implemented in conjunction with UCLA Health's larger quality improvement initiative (the My Action Plan Quality Improvement Initiative) in order to improve primary care preventive measure completion rates.

Conditions

Interventions

BEHAVIORAL

Persuasion via anecdote

The message will contain an anecdote of a patient whose cancer was caught early through similar, recommended preventive screenings. The message prompts patients to click on a link to read the story about the patient.

BEHAVIORAL

Persuasion via anecdote without link

The message will contain a link to an anecdote of a patient whose cancer was caught early through similar, recommended preventive screenings. The message won't contain a link to the story, but it will briefly describe the story.

BEHAVIORAL

Persuasion via research

This message will mention that research has shown promptly closing health gaps saves lives.The message will contain a link to an official website that supports the statement.

BEHAVIORAL

Reminder of preventive care measures

The investigators will send randomized participants an SMS reminder encouraging them to click the provided link and close their outstanding, overdue preventive care measures. The provided link will take them to their MyChart login page; after logging in, they would see their personalized My Action Plan Letter detailing their personalized, overdue preventive care measures.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-27
Primary Completion
2024-04-20
Completion
2024-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05979987 on ClinicalTrials.gov